AEON Biopharma, Inc.

Market Cap

$19M

Healthcare·Biotechnology·🇺🇸 United States·AMEX

Healthcare·Biotechnology·🇺🇸·AMEX

Stock Price

$0.72-$0.39 (-34.95%)

Jun 5, 2026

52W High $1.4052W Low $0.66

Company Details

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatmen...

CEO

—

IPO Date

Apr 12, 2021

Website

www.aeonbiopharma.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$60M

EPS (Diluted)

Free Cash Flow

-$12M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

Mar 31, 2026

FY 2025

Dec 31, 2025

Q4 2025

Dec 31, 2025

Q3 2025

Nov 14, 2025

Q2 2025

Aug 12, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee